These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 23518179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Marino P, Bellomo G, Sinigaglia F, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [Abstract] [Full Text] [Related]

  • 5. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
    Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS).
    Platelets; 2014 Mar; 25(5):367-72. PubMed ID: 24283589
    [Abstract] [Full Text] [Related]

  • 6. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G.
    J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. With the "universal definition," measurement of creatine kinase-myocardial band rather than troponin allows more accurate diagnosis of periprocedural necrosis and infarction after coronary intervention.
    Lim CC, van Gaal WJ, Testa L, Cuculi F, Arnold JR, Karamitsos T, Francis JM, Petersen SE, Digby JE, Westaby S, Antoniades C, Kharbanda RK, Burrell LM, Neubauer S, Banning AP.
    J Am Coll Cardiol; 2011 Feb 08; 57(6):653-61. PubMed ID: 21292125
    [Abstract] [Full Text] [Related]

  • 11. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
    Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Nardin M, Bellomo G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2015 Jan 08; 31(1):85-92. PubMed ID: 24898423
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Ceccon C, Nardin M, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Cardiovasc Revasc Med; 2018 Oct 08; 19(7 Pt A):744-750. PubMed ID: 29656938
    [Abstract] [Full Text] [Related]

  • 14. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention.
    Goncalves SC, Labinaz M, Le May M, Glover C, Froeschl M, Marquis JF, O'Brien E, Shukla D, Ruchin P, Sookur D, Ha A, So D.
    Am J Cardiol; 2011 Jan 15; 107(2):204-9. PubMed ID: 21129717
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention.
    Ang L, Thani KB, Ilapakurti M, Lee MS, Palakodeti V, Mahmud E.
    J Am Coll Cardiol; 2013 Jan 08; 61(1):23-34. PubMed ID: 23287370
    [Abstract] [Full Text] [Related]

  • 19. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M, Schaffer A, Barbieri L, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Atherosclerosis; 2014 Sep 08; 236(1):169-74. PubMed ID: 25055060
    [Abstract] [Full Text] [Related]

  • 20. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting.
    Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW.
    Heart; 2012 Oct 08; 98(19):1424-30. PubMed ID: 22821273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.